Next Article in Journal
Reduced Membrane-Bound Alkaline Phosphatase Does Not Affect Binding of Vip3Aa in a Heliothis virescens Resistant Colony
Next Article in Special Issue
Exploring Virulence Factors and Alternative Therapies against Staphylococcus aureus Pneumonia
Previous Article in Journal
The Southeast Alaska Tribal Ocean Research (SEATOR) Partnership: Addressing Data Gaps in Harmful Algal Bloom Monitoring and Shellfish Safety in Southeast Alaska
Previous Article in Special Issue
Allergy—A New Role for T Cell Superantigens of Staphylococcus aureus?
Review

Epidemiological and Clinical Evidence for the Role of Toxins in S. aureus Human Disease

by 1,2,3 and 1,2,3,*
1
Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
2
Vanderbilt Vaccine Research Program, Nashville, TN 37232, USA
3
Vanderbilt Institute for Infection, Immunology and Inflammation, Vanderbilt University Medical Center, Nashville, TN 37232, USA
*
Author to whom correspondence should be addressed.
Toxins 2020, 12(6), 408; https://doi.org/10.3390/toxins12060408
Received: 1 June 2020 / Revised: 12 June 2020 / Accepted: 15 June 2020 / Published: 19 June 2020
Staphylococcus aureus asymptomatically colonizes approximately 30–50% of the population and is a leading cause of bacteremia, bone/joint infections, and skin infections in the US. S. aureus has become a major public health threat due to antibiotic resistance and an increasing number of failed vaccine attempts. To develop new anti-staphylococcal preventive therapies, it will take a more thorough understanding of the current role S. aureus virulence factors play in contributing to human disease. This review focuses on the clinical association of individual toxins with S. aureus infection as well as attempted treatment options. Further understanding of these associations will increase understanding of toxins and their importance to S. aureus pathogenesis. View Full-Text
Keywords: Staphylococcus aureus; toxins; vaccines; monoclonal antibodies Staphylococcus aureus; toxins; vaccines; monoclonal antibodies
Show Figures

Figure 1

MDPI and ACS Style

Bennett, M.R.; Thomsen, I.P. Epidemiological and Clinical Evidence for the Role of Toxins in S. aureus Human Disease. Toxins 2020, 12, 408. https://doi.org/10.3390/toxins12060408

AMA Style

Bennett MR, Thomsen IP. Epidemiological and Clinical Evidence for the Role of Toxins in S. aureus Human Disease. Toxins. 2020; 12(6):408. https://doi.org/10.3390/toxins12060408

Chicago/Turabian Style

Bennett, Monique R., and Isaac P. Thomsen. 2020. "Epidemiological and Clinical Evidence for the Role of Toxins in S. aureus Human Disease" Toxins 12, no. 6: 408. https://doi.org/10.3390/toxins12060408

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop